OR WAIT null SECS
September 01, 2019
In an effort to secure a continuous, sustainable supply of an important vaccine ingredient, Agenus is turning to a plant cell-based cell culture method for production.
The evolution of cell-culture technology is driving the need for improvements in modeling solutions.
August 08, 2019
The company has launched new services for mammalian cell bank manufacturing under GMP conditions.
June 07, 2019
The $10-million investment will include a 500-L single-use perfusion bioreactor and seven patented downstream processing units.
January 17, 2019
Solentim and ATUM have announced a technology collaboration agreement that will focus on the creation of an efficient cell line development solution for biotherapeutic drug developers.
January 10, 2019
Agenus will leverage Selexis’ SUREtechnology Platform to progress Agenus’ portfolio of next-generation antibody programs.
December 01, 2018
This research proposes a method for separating and purifying tissue-type plasminogen activator from a fungal cell source.
November 01, 2018
This article will explore the requirements for media and supplements needed to maintain newer cell lines, such as those based on human cells and fungal cells.
October 15, 2018
The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.
July 12, 2018
Catalent Biologics will adopt Berkeley Lights’ Beacon optofluidic platform for its cell-line development workflow.